Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Bruntsch

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Deutsche Medizinische Wochenschrift (1946)|December 6, 1985
[Primary chemotherapy of advanced squamous epithelial carcinomas of the head and neck]U Bruntsch, T Hiller, H Wandt, et al.
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|January 1, 1975
[The primary extranodal manifestation of lympho- and reticulosarcoma of the stomach]H E Reis, S Passek, U Bruntsch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Lack of response in nine patients with breast cancer treated with fibroblast interferonU Bruntsch, G Groos, F J Tigges, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[New Chemotherapeutic possibilities in the management of metastasizing testicular teratomas]S Seeber, W M Gallmeier, K Höffken, et al.
Seminars in Oncology|October 1, 1994
Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agentsU Bruntsch, S Drechsler, J Eggert, et al.
Haematology and Blood Transfusion|January 1, 1977
Characterization of a human Hodgkin cell line and a lymphoblastic EBNA-negative cell line derived from a non-Hodgkin lymphoma patientW M Gallmeier, W R Boecker, U Bruntsch, et al.
Deutsche Medizinische Wochenschrift (1946)|June 13, 1975
[New chemotherapy (adriamycin, belomycin and vincristin) of metastasizing malignant testicular teratoma (author's transl)]S Seeber, W M Gallmeier, K Höffken, et al.
Investigational New Drugs|January 1, 1985
Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysineU Bruntsch, G Groos, T A Hiller, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials GroupS Gundersen, P Dombernowsky, F Cavalli, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|April 1, 1977
[Chemotherapy of malignant bone tumors]K Höffken, S Seeber, W M Gallmeier, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Deutsche Medizinische Wochenschrift (1946)|December 6, 1985
[Primary chemotherapy of advanced squamous epithelial carcinomas of the head and neck]U Bruntsch, T Hiller, H Wandt, et al.
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|January 1, 1975
[The primary extranodal manifestation of lympho- and reticulosarcoma of the stomach]H E Reis, S Passek, U Bruntsch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Lack of response in nine patients with breast cancer treated with fibroblast interferonU Bruntsch, G Groos, F J Tigges, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[New Chemotherapeutic possibilities in the management of metastasizing testicular teratomas]S Seeber, W M Gallmeier, K Höffken, et al.
Seminars in Oncology|October 1, 1994
Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agentsU Bruntsch, S Drechsler, J Eggert, et al.
Haematology and Blood Transfusion|January 1, 1977
Characterization of a human Hodgkin cell line and a lymphoblastic EBNA-negative cell line derived from a non-Hodgkin lymphoma patientW M Gallmeier, W R Boecker, U Bruntsch, et al.
Deutsche Medizinische Wochenschrift (1946)|June 13, 1975
[New chemotherapy (adriamycin, belomycin and vincristin) of metastasizing malignant testicular teratoma (author's transl)]S Seeber, W M Gallmeier, K Höffken, et al.
Investigational New Drugs|January 1, 1985
Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysineU Bruntsch, G Groos, T A Hiller, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials GroupS Gundersen, P Dombernowsky, F Cavalli, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|April 1, 1977
[Chemotherapy of malignant bone tumors]K Höffken, S Seeber, W M Gallmeier, et al.
Pageof 10